Latest Articles

Publication Date
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial - Medpage Today

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial Medpage Today

Published: Feb. 5, 2025, 5:54 p.m.
Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent - Imaging Technology News

Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent Imaging Technology News

Published: Feb. 5, 2025, 3:56 p.m.
Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent - StreetInsider.com

Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent StreetInsider.com

Published: Feb. 5, 2025, 1:51 p.m.
Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent - Yahoo Finance

Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent Yahoo Finance

Published: Feb. 5, 2025, 1:51 p.m.
A Case of Postoperative Lymphatic Ascites in Endometrial Cancer Spontaneously Resolving After Approximately One Year of Watchful Waiting - Cureus

A Case of Postoperative Lymphatic Ascites in Endometrial Cancer Spontaneously Resolving After Approximately One Year of Watchful Waiting Cureus

Published: Feb. 5, 2025, 1:26 p.m.
Correlation of ferritin and glutathione peroxidase 4 (GPX4) level as a marker of ferroptosis process in endometrioma - Nature.com

Correlation of ferritin and glutathione peroxidase 4 (GPX4) level as a marker of ferroptosis process in endometrioma Nature.com

Published: Feb. 5, 2025, 12:28 p.m.
Local couples chase a Big Miracle - The Western Weekender

Local couples chase a Big Miracle The Western Weekender

Published: Feb. 5, 2025, 4:09 a.m.
Endometriosis, Lyv Healthcare raises 2.6 million euros to impose e-health in the management of chronic female diseases - Businesslife.co

Endometriosis, Lyv Healthcare raises 2.6 million euros to impose e-health in the management of chronic female diseases Businesslife.co

Published: Feb. 5, 2025, 3:32 a.m.
Unraveling the role of lncRNA in Endometriosis-Associated immune system Dysregulation: Exploring the intricate immunological changes and disrupted signaling pathways.

A chronic illness known as endometriosis impacts women who are of reproductive maturity. It may be a factor in fertility problems, breast or ovarian cancer, asthma, cardiovascular illness, or pelvic …

Published: Feb. 5, 2025, midnight
Bringing Endometriosis to the Road of Contemporary Pain Science.

Endometriosis pain is mainly understood based on peripheral lesion characteristics and an outdated perspective equating nociception with pain. This limited view may divert understanding of interventions beyond peripheral logic, leading …

Published: Feb. 5, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!